Malin Löfdahl

Malin Löfdahl (fd Haeggström) has worked in a number of roles in the manufacturing and pharmaceutical industries since 2007. Malin began their career at AstraZeneca as an Analytiker in 2007, before moving to Recipharm as a Processingenjör in 2009. From 2011 to 2019, they worked at Cobra Biologics in a variety of roles, including Head of Clinical Production, Team Manager, Teamansvarig, and Valideringsingenjör. During this period, they also held roles at Valneva and AstraZeneca as a Senior Project Management Consultant. In 2021, they became an Interim QA Director (consultant) at Vironova AB and in 2022, they were appointed Head of Manufacturing Development at Anocca AB.

Malin Löfdahl (fd Haeggström) obtained a Bachelor's degree in Pharmacy from Södertörn University between 1997 and 2000. Malin then went on to earn a PhD in Microbiology from Karolinska Institutet between 2000 and 2006.